USP15 Participates in Hepatitis C Virus Propagation through Regulation of Viral RNA Translation and Lipid Droplet Formation.


Journal

Journal of virology
ISSN: 1098-5514
Titre abrégé: J Virol
Pays: United States
ID NLM: 0113724

Informations de publication

Date de publication:
15 03 2019
Historique:
received: 30 09 2018
accepted: 23 12 2018
pubmed: 11 1 2019
medline: 20 11 2019
entrez: 11 1 2019
Statut: epublish

Résumé

Hepatitis C virus (HCV) utilizes cellular factors for efficient propagation. Ubiquitin is covalently conjugated to the substrate to alter its stability or to modulate signal transduction. In this study, we examined the importance of ubiquitination for HCV propagation. We found that inhibition of deubiquitinating enzymes (DUBs) or overexpression of nonspecific DUBs impaired HCV replication, suggesting that ubiquitination regulates HCV replication. To identify specific DUBs involved in HCV propagation, we set up RNA interference (RNAi) screening against DUBs and successfully identified ubiquitin-specific protease 15 (USP15) as a novel host factor for HCV propagation. Our studies showed that USP15 is involved in translation of HCV RNA and production of infectious HCV particles. In addition, deficiency of USP15 in human hepatic cell lines (Huh7 and Hep3B/miR-122 cells) but not in a nonhepatic cell line (293T cells) impaired HCV propagation, suggesting that USP15 participates in HCV propagation through the regulation of hepatocyte-specific functions. Moreover, we showed that loss of USP15 had no effect on innate immune responses

Identifiants

pubmed: 30626683
pii: JVI.01708-18
doi: 10.1128/JVI.01708-18
pmc: PMC6401473
pii:
doi:

Substances chimiques

RNA, Viral 0
USP15 protein, human EC 3.4.19.12
Ubiquitin-Specific Proteases EC 3.4.19.12

Types de publication

Journal Article Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Informations de copyright

Copyright © 2019 American Society for Microbiology.

Références

J Gen Virol. 1995 Jan;76 ( Pt 1):53-61
pubmed: 7844542
Gene. 1991 Dec 15;108(2):193-9
pubmed: 1660837
J Virol. 2005 Jan;79(2):1271-81
pubmed: 15613354
Proc Natl Acad Sci U S A. 2007 Apr 3;104(14):5848-53
pubmed: 17376867
Sci Rep. 2013 Nov 27;3:3355
pubmed: 24284873
J Virol. 2003 Apr;77(7):4160-8
pubmed: 12634374
Nat Immunol. 2014 Jun;15(6):562-70
pubmed: 24777531
J Virol. 2012 Feb;86(3):1382-93
pubmed: 22114337
Nucleic Acids Res. 2017 Dec 1;45(21):12441-12454
pubmed: 29040738
PLoS Pathog. 2013 Mar;9(3):e1003285
pubmed: 23555273
Cell. 2009 Nov 25;139(5):855-60
pubmed: 19945371
Gastroenterology. 2010 May;138(5):1909-19
pubmed: 19909748
Biochim Biophys Acta. 2009 Jun;1791(6):419-40
pubmed: 19375517
Nat Cell Biol. 2011 Sep 25;13(11):1368-75
pubmed: 21947082
EMBO J. 2006 Oct 18;25(20):5015-25
pubmed: 17024179
J Virol. 2004 Nov;78(21):12047-53
pubmed: 15479844
Proc Natl Acad Sci U S A. 2007 Jan 30;104(5):1661-6
pubmed: 17234812
Sci Rep. 2015 Jun 10;5:11220
pubmed: 26061460
Proc Natl Acad Sci U S A. 2005 Feb 15;102(7):2561-6
pubmed: 15699349
Cell Host Microbe. 2014 Nov 12;16(5):569-79
pubmed: 25525790
J Exp Med. 2008 Jul 7;205(7):1601-10
pubmed: 18591409
J Virol. 2011 Nov;85(21):10976-88
pubmed: 21865391
Traffic. 2008 Aug;9(8):1268-82
pubmed: 18489704
Gastroenterology. 2004 Mar;126(3):840-8
pubmed: 14988838
Nucleic Acids Res. 2011 Sep 1;39(17):7716-29
pubmed: 21653556
J Virol. 2016 Jul 11;90(15):6832-45
pubmed: 27194766
J Mol Biol. 2009 Mar 6;386(4):1011-23
pubmed: 19211026
J Biol Chem. 1998 Oct 2;273(40):26138-48
pubmed: 9748295
J Virol. 2009 Sep;83(17):8885-92
pubmed: 19553310
Science. 1999 Jul 2;285(5424):110-3
pubmed: 10390360
Cell Host Microbe. 2009 Mar 19;5(3):298-307
pubmed: 19286138
J Virol. 2007 Dec;81(24):13783-93
pubmed: 17913825
Biochem J. 1973 Feb;132(2):323-7
pubmed: 4353447
J Virol. 2014 Jul;88(13):7199-209
pubmed: 24719423
J Virol. 2004 Aug;78(15):7958-68
pubmed: 15254168
J Virol. 2011 Nov;85(22):12087-92
pubmed: 21917968
Proc Natl Acad Sci U S A. 2014 Apr 29;111(17):6413-8
pubmed: 24733894
Cell Cycle. 2012 Jan 15;11(2):277-85
pubmed: 22189820
Biochem Biophys Res Commun. 2016 Sep 9;478(1):363-370
pubmed: 27416755
Proc Natl Acad Sci U S A. 2012 Jan 17;109(3):941-6
pubmed: 22215596
RNA. 2009 Aug;15(8):1528-42
pubmed: 19541769
Science. 2005 Sep 2;309(5740):1577-81
pubmed: 16141076
Oncogene. 1997 Jan 30;14(4):405-14
pubmed: 9053837
J Virol. 2011 Aug;85(16):7954-64
pubmed: 21632751
Cell Host Microbe. 2011 Jan 20;9(1):32-45
pubmed: 21238945
Mol Cell. 2013 Jul 11;51(1):68-79
pubmed: 23727018
J Virol. 2007 Feb;81(3):1174-85
pubmed: 17108031
J Virol. 2008 Sep;82(17):8349-61
pubmed: 18562515
Cell. 2016 Jun 30;166(1):152-66
pubmed: 27368102
Nature. 2008 Jul 24;454(7203):523-7
pubmed: 18548002
Cell Host Microbe. 2008 Jul 17;4(1):77-85
pubmed: 18621012
Proc Natl Acad Sci U S A. 2007 Nov 20;104(47):18666-70
pubmed: 18003907
J Virol. 2003 Apr;77(7):4149-59
pubmed: 12634373
Nat Struct Mol Biol. 2010 Aug;17(8):939-47
pubmed: 20622874
Nat Med. 1998 Sep;4(9):1065-7
pubmed: 9734402
Nat Cell Biol. 2007 Sep;9(9):1089-97
pubmed: 17721513
Nat Med. 2012 Feb 19;18(3):429-35
pubmed: 22344298
Sci Signal. 2014 Jan 07;7(307):ra3
pubmed: 24399297
Proc Natl Acad Sci U S A. 1997 Feb 18;94(4):1200-5
pubmed: 9037030
Virology. 2002 Jan 20;292(2):198-210
pubmed: 11878923
Biochem Biophys Res Commun. 2004 May 21;318(1):275-80
pubmed: 15110784
PLoS Pathog. 2011 Oct;7(10):e1002289
pubmed: 22022264
Virology. 2004 Jul 1;324(2):450-61
pubmed: 15207630
Virus Res. 2016 Sep 2;223:161-9
pubmed: 27460547
PLoS Pathog. 2014 Dec 11;10(12):e1004534
pubmed: 25502789
J Virol. 2012 Nov;86(21):11919-25
pubmed: 22896615
Best Pract Res Clin Gastroenterol. 2012 Aug;26(4):401-12
pubmed: 23199500
Hepatology. 2002 Apr;35(4):937-46
pubmed: 11915042
Curr Opin Clin Nutr Metab Care. 2013 Nov;16(6):632-7
pubmed: 24100667
Biochem Biophys Res Commun. 2016 Jun 17;475(1):31-6
pubmed: 27157138
Cell. 2013 Jul 3;154(1):169-84
pubmed: 23827681
Med Sci Monit. 2016 Jul 06;22:2347-56
pubmed: 27381636
J Virol. 2016 Jan 20;90(7):3530-42
pubmed: 26792738
Sci Rep. 2017 Jan 11;7:40246
pubmed: 28074857
Cell Microbiol. 2017 Apr;19(4):
pubmed: 27665576
Virology. 1996 Aug 1;222(1):31-42
pubmed: 8806485
Proc Natl Acad Sci U S A. 2008 Mar 18;105(11):4370-5
pubmed: 18334634
Nat Commun. 2016 May 04;7:11379
pubmed: 27142248
PLoS Pathog. 2009 Aug;5(8):e1000546
pubmed: 19680534
Proc Natl Acad Sci U S A. 2009 May 5;106(18):7577-82
pubmed: 19376974
J Lipid Res. 1997 Nov;38(11):2249-63
pubmed: 9392423
J Clin Invest. 1998 Jun 1;101(11):2331-9
pubmed: 9616204
Cell Host Microbe. 2015 Feb 11;17(2):217-28
pubmed: 25662750
Nature. 2006 May 4;441(7089):101-5
pubmed: 16625202
J Biol Chem. 2014 Mar 28;289(13):8916-30
pubmed: 24526689
PLoS Pathog. 2013;9(4):e1003302
pubmed: 23593007
J Biol Chem. 2007 Dec 21;282(51):37158-69
pubmed: 17942391
J Gastrointestin Liver Dis. 2007 Mar;16(1):65-73
pubmed: 17410291
Sci Rep. 2015 Nov 16;5:16699
pubmed: 26567527

Auteurs

Shinji Kusakabe (S)

Department of Molecular Virology, Research Institute for Microbial Diseases, Osaka University, Osaka, Japan.

Tatsuya Suzuki (T)

Department of Molecular Virology, Research Institute for Microbial Diseases, Osaka University, Osaka, Japan.

Yukari Sugiyama (Y)

Department of Molecular Virology, Research Institute for Microbial Diseases, Osaka University, Osaka, Japan.

Saori Haga (S)

Department of Molecular Virology, Research Institute for Microbial Diseases, Osaka University, Osaka, Japan.

Kanako Horike (K)

Department of Molecular Virology, Research Institute for Microbial Diseases, Osaka University, Osaka, Japan.

Makoto Tokunaga (M)

Department of Molecular Virology, Research Institute for Microbial Diseases, Osaka University, Osaka, Japan.

Junki Hirano (J)

Department of Molecular Virology, Research Institute for Microbial Diseases, Osaka University, Osaka, Japan.

He Zhang (H)

Department of Molecular Virology, Research Institute for Microbial Diseases, Osaka University, Osaka, Japan.

David Virya Chen (DV)

Department of Molecular Virology, Research Institute for Microbial Diseases, Osaka University, Osaka, Japan.

Hanako Ishiga (H)

Department of Molecular Virology, Research Institute for Microbial Diseases, Osaka University, Osaka, Japan.

Yasumasa Komoda (Y)

Department of Molecular Virology, Research Institute for Microbial Diseases, Osaka University, Osaka, Japan.

Chikako Ono (C)

Department of Molecular Virology, Research Institute for Microbial Diseases, Osaka University, Osaka, Japan.

Takasuke Fukuhara (T)

Department of Molecular Virology, Research Institute for Microbial Diseases, Osaka University, Osaka, Japan.

Masahiro Yamamoto (M)

Department of Immunoparasitology, Research Institute for Microbial Diseases, Osaka University, Osaka, Japan.

Masahito Ikawa (M)

Department of Experimental Genome Research, Research Institute for Microbial Diseases, Osaka University, Osaka, Japan.

Takashi Satoh (T)

Department of Host Defense, Research Institute for Microbial Diseases, Osaka University, Osaka, Japan.

Shizuo Akira (S)

Department of Host Defense, Research Institute for Microbial Diseases, Osaka University, Osaka, Japan.

Tomohisa Tanaka (T)

Department of Microbiology, Faculty of Medicine, University of Yamanashi, Yamanashi, Japan.

Kohji Moriishi (K)

Department of Microbiology, Faculty of Medicine, University of Yamanashi, Yamanashi, Japan.

Moto Fukai (M)

Department of Gastroenterological Surgery I, Hokkaido University Graduate School of Medicine, Sapporo, Japan.

Akinobu Taketomi (A)

Department of Gastroenterological Surgery I, Hokkaido University Graduate School of Medicine, Sapporo, Japan.

Sachiyo Yoshio (S)

Research Center for Hepatitis and Immunology, National Center for Global Health and Medicine, Ichikawa, Japan.

Tatsuya Kanto (T)

Research Center for Hepatitis and Immunology, National Center for Global Health and Medicine, Ichikawa, Japan.

Tetsuro Suzuki (T)

Department of Virology and Parasitology, Hamamatsu University School of Medicine, Hamamatsu, Japan.

Toru Okamoto (T)

Department of Molecular Virology, Research Institute for Microbial Diseases, Osaka University, Osaka, Japan toru@biken.osaka-u.ac.jp matsuura@biken.osaka-u.ac.jp.

Yoshiharu Matsuura (Y)

Department of Molecular Virology, Research Institute for Microbial Diseases, Osaka University, Osaka, Japan toru@biken.osaka-u.ac.jp matsuura@biken.osaka-u.ac.jp.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH